Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV001783466 | SCV002810624 | likely pathogenic | Cranioectodermal dysplasia 1 | 2022-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003416445 | SCV004117488 | likely pathogenic | IFT122-related disorder | 2023-01-24 | criteria provided, single submitter | clinical testing | The IFT122 c.366_376del11 variant is predicted to result in a frameshift and premature protein termination (p.Gly123Glufs*3). This variant was reported in an individual with cranioectodermal dysplasia (Yang et al. 2021. PubMed ID: 33717254). This variant is reported in 0.0054% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-129179789-AAGGCCAAGGTG-A). Frameshift variants in IFT122 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |
OMIM | RCV001783466 | SCV002041899 | pathogenic | Cranioectodermal dysplasia 1 | 2021-12-22 | no assertion criteria provided | literature only |